CARL vs EMBC: stock comparison and AI forecast
Carlsmed, Inc. (CARL) and Embecta Corp. (EMBC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CARL Carlsmed, Inc.
- Price
- $14.40 +61.4% · 6M
- Market Cap
- $393M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
EMBC Embecta Corp.
- Market Cap
- $354M
- P/E Ratio
- 5.2x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CARL is 1.1 times larger than EMBC by market capitalization ($393M against $354M).
- EMBC turns 8.6% of its revenue into net income, against -57.3% for CARL.
- EMBC yields 12.71% in dividends; CARL pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CARL | EMBC |
|---|---|---|
| Market Cap | $393M | $354M |
| P/E Ratio | – | 5.21x |
| P/B Ratio | 4.67x | – |
| Dividend Yield | – | 12.71% |
| EPS | $-1.04 | $1.20 |
| Book Value/Share | $3.09 | – |
| Revenue/Share | $2.69 | $17.98 |
| FCF/Share | $-1.27 | $2.91 |
Profitability & Margins
| Metric | CARL | EMBC |
|---|---|---|
| ROE | -49.9% | – |
| ROA | -35.6% | 6.9% |
| ROIC | -42.0% | 26.4% |
| Gross Margin | 76.4% | 59.0% |
| Operating Margin | -60.4% | 21.9% |
| Net Margin | -57.3% | 8.6% |
| EBT Margin | -60.4% | 12.2% |
| Tax Rate | 0.0% | 30.2% |
Financial Health
| Metric | CARL | EMBC |
|---|---|---|
| Current Ratio | 8.84x | 1.68x |
| Quick Ratio | 8.66x | 1.17x |
| D/E Ratio | 0.40x | – |
| Financial Leverage | 1.40x | – |
| Interest Coverage | -35.3x | 4.0x |
| Working Capital | $97M | $285M |
Cash Flow
| Metric | CARL | EMBC |
|---|---|---|
| Operating Cash Flow | -$34M | $174M |
| Free Cash Flow | -$35M | $165M |
| Capital Spending | -$430K | -$10M |
| OCF Growth YoY | – | 29.6% |
| FCF Growth YoY | – | 24.4% |
| FCF/Sales | -47.0% | 16.2% |
| CapEx/Sales | 0.6% | 0.9% |
Operational Efficiency
| Metric | CARL | EMBC |
|---|---|---|
| Asset Turnover | 0.62x | 0.81x |
| Receivables Turnover | 5.3x | 5.6x |
| Inventory Turnover | 7.6x | 1.9x |
| Fixed Assets Turnover | 30.6x | 3.5x |
| Days Sales Outstanding | 68 days | 65 days |
| Days Inventory | 48 days | 187 days |
| Payables Period | 78 days | – |
| Cash Conversion Cycle | 38 days | – |
Income Statement
| Metric | CARL | EMBC |
|---|---|---|
| Total Revenue | $73M | $1.02B |
| Operating Income | -$44M | $224M |
| Net Income | -$42M | $88M |
| R&D Expense | $24M | $20M |
| SG&A Expense | $89M | $319M |
| Cost of Goods Sold | $17M | $417M |
Dividend & Shareholder Information
| Metric | CARL | EMBC |
|---|---|---|
| Dividends Per Share | – | $0.79 |
| Payout Ratio | – | 65.8% |
| Shares Outstanding | 27M | 57M |
| Net Income Growth | – | 4.7% |
| EPS Growth | – | -35.8% |
CARL vs EMBC: stock comparison and AI forecast
Which is bigger, CARL or EMBC?
CARL is 1.1 times larger than EMBC by market capitalization ($393M against $354M).
Which one does Intratio's AI model rank higher, CARL or EMBC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.